In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Solventum's current price at $78.87 is substantially below the $120.05 fair value, signaling notable undervaluation with a potential upside exceeding 50%. High confidence in DCF and analyst targets contrasts with low growth scores, indicating profitability but limited expansion. Monte Carlo's wide value range and 11.1% downside risk reflect significant volatility and moderate downside exposure relative to the current price.